MannKind | Rörelseresultat



Operating Profit Ändra Datum
Adma Biologics USD 37.08M 2.56M 2024-12
Dynavax Technologies USD -1632000 11.71M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Insmed USD -230414000 16.98M 2024-12
MacroGenics USD 54.19M 112.37M 2024-09
MannKind USD 13.1M 4.92M 2024-12
Merck USD 4.3B 369M 2024-12
Novo Nordisk DKK 33.82B 7.89B 2024-09
Pfizer USD -409000000 5.57B 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
Xencor USD 4.05M 66.33M 2024-12



MannKind Rörelseresultat - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.